About This Investor
JP-B-289
Budget guidance is $6.54M – $32.7M. From Japan, they are evaluating both investment and acquisition structures depending on the case. Priority theme: Businesses that handle OTC drugs (i.e., have OTC brands) Businesses that own healthcare product brands. They are prioritizing Priority countries: Thailand, Singapore, Malaysia, Vietnam, Indonesia, Philippines Countries eligible for consideration: Asia. Majority ownership…
Request Full Investor Profile
Similar Investors
JP-B-74
Search focus: Key target profile: Construction equipment rental business. From
JP-B-430
They are currently building a shortlist and welcome relevant introductions.
JP-B-368
Geographic and deal conditions are important for this mandate: Worldwide.